1. Distal Versus Proximal Radial Artery Access for Cardiac Catheterization and Intervention: Design and Rationale of the DIPRA Trial.
- Author
-
Al-Azizi, Karim M., Idris, Amr, Christensen, Jared, Hamandi, Mohanad, Hale, Sarah, Martits-Chalangari, Katalin, Van Zyl, Johanna S., Ravindranathan, Preethi, Banwait, Jasjit K., Mcckracken, Julie, Smith, Adam, Apakama, Ginika, Swim, Jennifer, Dolton, Penni, Chionh, Kristen, Dimaio, Michael, Thomas, Sibi, Szerlip, Molly, Sayfo, Sameh, and Dib, Chadi
- Subjects
- *
RADIAL artery , *CARDIAC catheterization , *CORONARY artery bypass , *CORONARY artery surgery , *RADIAL nerve , *FEMORAL artery , *INTRAVENOUS catheterization , *RESEARCH , *RESEARCH methodology , *MEDICAL care , *EVALUATION research , *CARDIOVASCULAR system , *TREATMENT effectiveness , *CORONARY angiography , *COMPARATIVE studies , *RANDOMIZED controlled trials , *LONGITUDINAL method - Abstract
Background: Radial artery (RA) catheterization is the access of choice over femoral artery access for most interventional vascular procedures given its safety and faster patient recovery. There has been growing interest in distal radial artery (dRA) access as an alternative to the conventional proximal radial artery (pRA) access. Preserving the RA is important which serves as a potential conduit for future coronary artery bypass surgery, dialysis conduit or preserve the artery for future cardiovascular procedures. The dRA runs in close proximity to the radial nerve, which raises the concern of potential detrimental effects on hand function.Study Design: The Distal versus Proximal Radial Artery Access for cardiac catheterization and intervention (DIPRA) trial is a prospective, randomized, parallel-controlled, open-label, single center study evaluating the outcomes of hand function and effectiveness of dRA compared to pRA access in patients undergoing cardiac catheterization. The eligible subjects will be randomized to dRA and pRA access in a (1:1) fashion. The primary end point is an evaluation of hand function at one and twelve months follow-up. Secondary end points include rates of access site hematoma, access site bleeding, other vascular access complications, arterial access success rate, and RA occlusion at one and twelve months follow up.Conclusion: Effects of dRA on hand function remains unknown and it's use questionable in the presence of a widely accepted pRA. DIPRA trial is designed to determine the safety and effectiveness of dRA for diagnostic and interventional cardiovascular procedures compared to the standard of care pRA. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF